Phase I data presented for AXL inhibitor DS-1205c plus osimertinib in EGFR-mutated NSCLC Feb. 3, 2021
Cassava Sciences presents interim analysis data for simufilam in patients with Alzheimer's disease Feb. 3, 2021
RSS